P

Inventor

CLADER JOHN W

US55 patents
⚠️ This page may combine multiple inventors who share the name “CLADER JOHN W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING CORP

42 patents
USRE37721EMay 28, 2002

Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents

SCHERING CORP99 citations99
US5846966ADec 8, 1998

Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors

SCHERING CORP171 citations99
US5883096AMar 16, 1999

Muscarinic antagonists

SCHERING CORP164 citations98
US6689765B2Feb 10, 2004

Piperazine derivatives useful as CCR5 antagonists

SCHERING CORP71 citations97
US6391865B1May 21, 2002

Piperazine derivatives useful as CCR5 antagonists

SCHERING CORP94 citations97
US6037352AMar 14, 2000

Muscarinic antagonists

SCHERING CORP90 citations97
US5889006AMar 30, 1999

Muscarinic antagonists

SCHERING CORP123 citations97
US5656624AAug 12, 1997

4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents

SCHERING CORP115 citations97
US6387930B1May 14, 2002

Piperidine derivatives useful as CCR5 antagonists

SCHERING CORP76 citations96
US6294554B1Sep 25, 2001

Muscarinic antagonists

SCHERING CORP70 citations96
US5698548ADec 16, 1997

Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents

SCHERING CORP88 citations96
US5688787ANov 18, 1997

Substituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof

SCHERING CORP90 citations96
US6043255AMar 28, 2000

Muscarinic antagonists

SCHERING CORP50 citations95
US5238950AAug 24, 1993

Inhibitors of platelet-derived growth factor

SCHERING CORP135 citations95
US6969719B2Nov 29, 2005

Polycyclic guanine phosphodiesterase V inhibitors

SCHERING CORP59 citations94
US7208486B2Apr 24, 2007

Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof

SCHERING CORP16 citations93
US7122675B2Oct 17, 2006

Gamma secretase inhibitors

SCHERING CORP24 citations92
US6900329B2May 31, 2005

MCH antagonists and their use in the treatment of obesity

SCHERING CORP18 citations92
US6602885B2Aug 5, 2003

Piperidine derivatives useful as CCR5 antagonists

SCHERING CORP21 citations92
US6288068B1Sep 11, 2001

Muscarinic antagonists

SCHERING CORP22 citations91
US6472394B1Oct 29, 2002

MCH antagonists and their use in the treatment of obesity

SCHERING CORP24 citations89
USRE42461EJun 14, 2011

Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents

SCHERING CORP7 citations84
US7368562B2May 6, 2008

Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof

SCHERING CORP10 citations84
US7235543B2Jun 26, 2007

Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof

SCHERING CORP13 citations84
US5302716AApr 12, 1994

Fused benzazepines

SCHERING CORP11 citations74
US4973586ANov 27, 1990

Fused benzazepines, compositions of, and medical use thereof

SCHERING CORP18 citations74
US7384944B2Jun 10, 2008

Piperazine derivatives useful as CCR5 antagonists

SCHERING CORP6 citations73
US6943171B2Sep 13, 2005

Polycyclic guanine derivative phosphodiesterase V inhibitors

SCHERING CORP11 citations73
US6498168B2Dec 24, 2002

Muscarinic antagonists

SCHERING CORP5 citations73
US5362728ANov 8, 1994

4,5-bridged-2,3,4,5-tetrahydro-1H-3-benzazepine-7-ols and derivatives and compositions and methods employing such compounds

SCHERING CORP7 citations73
US7256186B2Aug 14, 2007

Gamma secretase inhibitors

SCHERING CORP8 citations71
US7459442B2Dec 2, 2008

Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof

SCHERING CORP3 citations63
US7192944B2Mar 20, 2007

Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof

SCHERING CORP4 citations63
US5374722ADec 20, 1994

Bridged benzazepines

SCHERING CORP5 citations63
US5416118AMay 16, 1995

Bicyclic amides as inhibitors of acyl-coenzyme A: cholesterol acyl transferase

SCHERING CORP3 citations58
US7741289B2Jun 22, 2010

Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof

SCHERING CORP0 citations52
US7732413B2Jun 8, 2010

Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof

SCHERING CORP0 citations52
US7452891B2Nov 18, 2008

MCH antagonists and their use in the treatment of obesity

SCHERING CORP0 citations52
US7378518B2May 27, 2008

Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof

SCHERING CORP0 citations52
US7368563B2May 6, 2008

Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof

SCHERING CORP0 citations52
US6689783B2Feb 10, 2004

Aryl oxime-piperazines useful as CCR5 antagonists

SCHERING CORP6 citations52
US7998958B2Aug 16, 2011

Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors

SCHERING CORP0 citations51

ASBEROM THEODROS

3 patents

SCHERING PLOUGH CORP

1 patent

HOFFMANN LA ROCHE

1 patent

WU WEN-LIAN

1 patent

PHARACOPEIA DRUG DISCOVERY INC

1 patent

ZHU ZHAONING

1 patent

Showing the top 50 of 55 patents by PatentIndex Score.